Vitamin D Testing Market , 35% of Growth to Originate from North America, Technavio

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The global vitamin D testing market size is estimated to grow by USD 182.6 million from 2024 to 2028, according to Technavio. The market is estimated to grow at a CAGR of over 4.96% during the forecast period.

Technavio has announced its latest market research report titled Global vitamin D testing market 2024-2028
Technavio has announced its latest market research report titled Global vitamin D testing market 2024-2028

For comprehensive forecast and historic data on regions,market segments, customer landscape, and companies- Click for the snapshot of this report

Report Attribute

Details

Base Year

2023

Forecast period

2024-2028

Historic Data for

2018 - 2022

Segments Covered

Product (25-hydroxyvitamin D testing and 1 25-dihydroxyvitamin D testing), End-user (Diagnostic laboratories, Hospitals and physician clinics, and Home care settings), Geography (North America, Europe, Asia, and Rest of World (ROW)), Technology (), and Indication ()

Key Companies Covered

Abbott, Danaher, F. Hoffmann-La Roche Ltd, Siemens, Quest Diagnostics Incorporated, bioMérieux SA, DiaSorin S.p.A., Thermo Fisher Scientific Inc., Beckman Coulter, Inc. (BD), Tosoh Bioscience, Inc., Biohit Oyj, BioVendor Laboratorni medicina AS, Boditech Med Inc., DiaSys Diagnostic Systems GmbH, Everly Health Inc., Laboratory Corp. of America Holdings, Qualigen Therapeutics Inc., Quidelortho Corp., Randox Laboratories Ltd., Recipe Chemicals and Instruments GmbH.

Regions Covered

North America, Europe, Asia, and Rest of World (ROW)

Region Outlook

  1. North America

  2. Europe

  3. Asia

  4. Rest of World

1. North America - North America is estimated to contribute 35%. To the growth of the global market. The Vitamin D Testing Market report forecasts market growth by revenue at global, regional & country levels from 2017 to 2027.

The North American region dominated the global vitamin D testing market in 2023, accounting for the largest share. The US, in particular, led this segment due to the presence of numerous vendors such as Abbott, Danaher, and Quest Diagnostics Inc. (Quest Diagnostics). These companies provide a wide range of vitamin D testing products, including Abbott's ARCHITECT 25-OH Vitamin D assay, which is a chemiluminescent microparticle immunoassay (CMIA) used for quantitative measurement of 25-hydroxyvitamin D in human plasma and serum, enabling assessment of vitamin D sufficiency.

For more insights on North America's significant contribution along with the market share of rest of the regions and countries - Download a FREE Sample

Segmentation Overview

  1. Product

  • 1.1 25-hydroxyvitamin D testing

  • 1.2 1 25-dihydroxyvitamin D testing

End-user

  • 2.1 Diagnostic laboratories

  • 2.2 Hospitals and physician clinics

  • 2.3 Home care settings